Topical Dermatitis Or Psoriasis Products
I am looking for a consultant on a project about market access for topical dermatitis or psoriasis products. The project will be a qualitative study with kols and payers. The consultant needs to serve as an expert to guide project design. The consultant should have experience in getting topical dermatitis or psoriasis products to market, understand the approval pathway, and have experience with payer and insurance organizations. The project is us based.
Please send a short bio describing relevant experience.+3 Other Responses
The zintro blog needs you!i'm looking for your expert opinion on the news below and a written response that is one to three paragraphs long.Your response may be used in an article that i will write and post on the zintro blog.You will be named in the article and a link to your profile will be included.Your contribution is voluntary(there is no direct payment involved, but you will get lots of traffic to your expert profile).If interested, please send me your response via znotes within the next few days.
Merckâs experimental drug shrank tumors in 38 percent of patients with advanced melanoma.The drugs disable a brake that prevents the immune system from attacking cancer cells.The brake is a protein on immune system cells called programmed death 1 receptor,or pd-1.Merck also plans to test the drug as a treatment for lung cancer, head and neck cancer,bladder cancer and hematologic cancers.Will it become one of the most promising drugs in years?
This is a great marketing opportunity to get your name and expert opinion published on our blog.Here is a sample: http://blog.Zintro.Com/2012/01/16/keystone-xl-pipeline-pros-and-cons/
please include your full name,we will link it to your expert profile,getting you more presence on zintro.If you have any questions,please let me know.
idil kan+3 Other Responses
Anti-acne drugs market: market dynamics, trends and forecast till 2014
we are looking for qualitative insight about following points:
â¢market dynamics / trends specifically for drugs like clindamycin, nicotinamide, adapelene, benzoyl peroxide with clindamycin, isotretinoin and tretenion, and erythromycin
â¢reasons for decline mainly for these drugs (especially for clindamycin, nicotinamide, adapelene, benzoyl peroxide with clindamycin, isotretinoin and tretenion, and erythromycin)
â¢reasons for decline in top countries like china, greece, france, hungary, slovakia, united kingdom, sweden, italy and switzerland
â¢drivers, restraints and opportunities in anti-acne market (especially for clindamycin, nicotinamide, adapelene, benzoyl peroxide with clindamycin, isotretinoin and tretenion, and erythromycin)+3 Other Responses